Brief: Inozyme Pharma Reports $73 Mln Underwritten Offering Priced At-The-Market
14/04/2022 13:24
April 14 (Reuters) - Inozyme Pharma Inc INZY.O :
* INOZYME PHARMA ANNOUNCES $73 MILLION UNDERWRITTEN OFFERING
PRICED AT-THE-MARKET
Source text for Eikon: ID:nGNXC17SQ
Further company coverage: INZY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inozyme Pharma
See all newsBrief: Inozyme Pharma postpones 2025 annual meeting of stockholders
U.S. RESEARCH ROUNDUP-Advansix, Cognizant, Inozyme Pharma
U.S. STOCKS ON THE MOVE-Netflix, Acadia Pharma, CoreWeave
U.S. STOCKS ON THE MOVE-Inozyme Pharma, Emerson Electric, Stanley Black & Decker
Inozyme Pharma rises over 175% on $270 million buyout deal with BioMarin